CIK 0001761612
- Non-accelerated filer
- Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $64,039
- in 7 filings, $7K under 10b5-1 plans
Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Lee Kevin −$27K CHIEF EXECUTIVE OFFICER sold 1% of stake
- Swanton Robert Charles −$12K Director sold 18% of stake
- Skynner Michael −$9K CHIEF SCIENTIFIC OFFICER sold 2% of stake
- Perry Jennifer Scott −$7K Chief Operating Officer sold 2% of stake
- Hannay Michael Charles Ferguson −$6K CHIEF PROD & SUPPLY CHAIN OFF sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +19,000 | 937,483 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +19,000 | 10,018,674 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +38,000 | 38,000 | ||
| 2026-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +38,000 | 38,000 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,400 | 918,483 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award | +4,400 | 9,999,674 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +8,801 | 8,801 | ||
| 2025-01-02 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +8,801 | 8,801 | ||
| 2024-12-16 | BAKER BROS. ADVISORS LP Director | Purchase | +42,369 | $15.34 | $650K | 914,083 |
| 2024-12-16 | BAKER BROS. ADVISORS LP Director | Purchase | +457,631 | $15.34 | $7.0M | 9,995,274 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +2,809 | $13.50 | $38K | 790,763 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +30,241 | $13.50 | $408K | 8,666,247 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +5,573 | $13.63 | $76K | 796,336 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +59,995 | $13.63 | $818K | 8,726,242 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +22,722 | $13.72 | $312K | 819,058 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +244,587 | $13.72 | $3.4M | 8,970,829 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +52,656 | $13.80 | $727K | 871,714 |
| 2024-12-13 | BAKER BROS. ADVISORS LP Director | Purchase | +566,814 | $13.80 | $7.8M | 9,537,643 |
| 2024-06-17 | BAKER BROS. ADVISORS LP Director | Conversion | +196,098 | 787,954 | ||
| 2024-06-17 | BAKER BROS. ADVISORS LP Director | Conversion | +2,186,686 | 8,636,006 |
Page 1 of 2 · 28 trades